We are live on ! Find out more
GTHX

G1 Therapeutics, Inc. Common Stock
GTHX

Delisted

GTHX was delisted on the 17th of September, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of GTHX yet.

GTHX Hedge Fund Activity: Q3 2024 in Review

0 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in G1 Therapeutics, Inc. Common Stock (GTHX) for Q3 2024, worth a combined $0 — down 100% from $45.5M a quarter earlier.

Sellers outnumbered buyers: 88 funds closed out of GTHX and 0 opened new positions — a net loss of 88 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $7.03M sold.

  • 0 institutional investors held G1 Therapeutics, Inc. Common Stock (GTHX) as of Q3 2024, down from 88 in Q2 2024.
  • Funds reported $0 of G1 Therapeutics, Inc. Common Stock stock for Q3 2024, down 100% quarter-over-quarter.
  • 0 funds opened new G1 Therapeutics, Inc. Common Stock positions in Q3 2024 and 88 closed out, a net change of -88 holders.
  • The largest G1 Therapeutics, Inc. Common Stock seller in Q3 2024 was BlackRock, an estimated $7.03M sold.

Based on aggregated 13F filings for Q3 2024.